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Introduction of Akt into WM35 cells results in increased intracellular ROS. 
(A) Quantitation of hydrogen peroxide by dichlorofluorescein (DCF) fluo-
rescence and of superoxide by dihydroethidium (DHE) fluorescence. (B) 
Akt overexpression led to increased expression of VEGF mRNA. (C) 
Increased expression of VEGF protein in WM35 cells overexpressing 
Akt compared with parental controls. Lane 1, WM35 cells; lane 2, WM35 
PKBDD cells; lane 3, pooled Akt-transduced WM35 cells. Tubulin is 
included as a loading control. Experiments were performed in triplicate.
Figure 2
Akt causes vertical growth melanoma in vivo. (A) Parental WM35 cells, pooled Akt-transduced WM35 cells prior to implantation in vivo (WM35 
PKB and WM35 PKBDD), and cells derived from tumors of mice injected with WM35 PKB cells (tum1–tum3) were examined for expression of 
phosphorylated Akt (p-Akt). The experiment was performed in triplicate. (B) Representative Western blot of phosphorylated Akt and α-tubulin; 
overexpression converted radial growth melanoma to vertical growth melanoma. (C and D) Mice (n = 4 per group) were injected with either vector 
control or Akt-expressing melanoma cells and were observed at 1 month. (E) Immunohistochemistry for VEGF. A high level of VEGF expres-
sion was noted, especially surrounding necrotic areas. (F) Smooth muscle actin immunohistochemistry, demonstrating that tumors were highly 
angiogenic. Note the invasion of tumor cells into vessel at the image’s center. Original magnification, ×100.
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angiogenic  (Figure 2F).  In order  to 
assess  the mechanism of  induction 















ROS  observed  in  Akt-transformed 
cells.  In contrast, WM35 PKB cells, 
which were in culture after Akt trans-
































Transfection of Akt induces NOX4 expression in melanoma cells. 
Levels of NOX4 in each sample were normalized to 18S RNA. Data 
represent a sample set of 5. In 2 separate experiments, NOX4 was 
observed in the WM35 PKB cells and not in the WM35 cells. A 1.5% 
agarose gel was run after PCR, and single bands for NOX4 and for 
18S were observed (not shown).
Figure 4
Akt inhibition downregulates VEGF, rictor, and Sirt1. (A) Triplicate analysis of pooled WM35 cells 
transfected with Akt demonstrated activation (phosphorylation) of JunD in melanoma tumors. Lane 1, 
WM35 cells; lane 2, WM35 PKBDD cells (which have numerous mitochondrial mutations); lane 3, 
pooled WM35 cells freshly transfected with active PKB prior to tumor implantation; lanes 4–6, pro-
tein from individual tumors derived after injection of pooled WM35 PKB cells into mice. (B–D) Akt 
inhibition in A375 melanoma cells resulted in downregulation of VEGF (B), rictor (C), and Sirt1 (D) 
RNA. A375 cells were treated with Akt inhibitor and harvested at 2 and 24 hours. RNA levels are 
corrected for 18S RNA, and experiments were performed in triplicate. *P < 0.05 versus vehicle.
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Introduction of Akt converted WM35 cells to glycolytic metabolism (Warburg effect). (A) Glycolysis rates were determined in the presence of oligomy-
cin. Results are mean ± SEM of 6 experiments. (B) Western blot analysis of mitochondrial β-F1-ATPase and Hsp60 and glycolytic enzyme GAPDH 
compared with tubulin, used as a loading control. (C) Relative expression level of the indicated mitochondrial markers as assessed by the β-F1-
ATPase/Hsp60 ratio and by GAPDH relative to tubulin. The bioenergetic cellular (BEC) index showed a significant decrease in WM35 PKB cells, 
consistent with their conversion to a glycolytic phenotype. Results are mean ± SEM of 4 experiments. **P < 0.01, #P < 0.0005 versus WM35.
Figure 6
Amplicon 1 TGCE electropherogram tracings for WM35 cells, WM35 
PKB cells, and the mixed sample. Amplicon 1 (spanning mitochondrial 
positions 16278–148) is a 440-bp fragment that was one of 3 from the 
17 total amplicons not subjected to restriction endonuclease treatment, 
yielding a single peak upon TGCE analysis, as shown for both the 
WM35 and the WM35 PKB homoduplexes. The mixed sample, how-
ever, consisted of a characteristic double peak, suggestive of nucleo-
tide differences between the 2 samples that led to the formation of both 
homoduplex and heteroduplex species that were resolved from one 
another in this assay.
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Summary of nucleotide differences between WM35 and WM35 PKB cells
	 MT-DLOOP	MT-ND1	 MT-ND2	 MT-CO1	 MT-CO2	 MT-ATP6	 MT-ND4	 MT-TS2	 MT-ND5	 MT-ND6	 MT-CYB	 Total
Nucleotide positions 16024– 3307– 4470– 5904– 7586– 8527– 10760– 12207– 12337– 14149– 14747– 
 576 4262 5511 7445 8269 9207 12137 12265 14148 14673 15887
Nucleotide changes 9 7 28 1 13 1 1 1 20 1 3 85
Transitions 9 3 16 1 3 1 1 0 5 0 3 42
Transversions 0 4 12 0 10 0 0 1 15 1 0 43
Synonymous changes – 2 7 0 3 0 1 – 2 0 1 16
Nonsynonymous changes – 5 21 1 10 1 0 – 18 1 2 59
Amino acid changes – 5 17 1 9 1 0 – 15 1 1 50
A total of 66 codons were impacted. “–” denotes no possible amino acid change because the gene does not encode a protein.
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Schematic of the 2 mechanisms by which Akt may transform cells. Akt 
may prevent cells that already have mtDNA mutations from undergo-
ing apoptosis or senescence due to ROS. Akt may also induce NOX4, 
which may increase the cells’ ability to generate ROS in vivo. Both 
mechanisms of ROS, in the presence of Akt, may lead to NF-κB activa-
tion and resistance to apoptosis.
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